August 06, 2013
Novartis Pharmaceuticals Corp. launched a lawsuit against Hospira Inc. in New Jersey federal court Friday seeking to block the company's attempt to manufacture and sell generic versions of Novartis' cancer therapy drug Zometa prior to expiration of two of its patents.